| Financial Year |
March 31 2023 |
| Monetary Funds |
2,283,918,870.17 |
| Held-for-trading Financial Assets |
116,175,840.33 |
| Notes Receivable |
20,844,173.96 |
| Accounts Receivable |
1,308,703,303.20 |
| Advances to Suppliers |
149,273,498.65 |
| Other Receivables |
92,131,853.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
855,968,441.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
528,182,560.03 |
| Total Current Assets |
5,403,038,734.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,063,074.49 |
| Investment Properties |
-- |
| Fixed Assetes |
2,904,423,173.07 |
| Under-construction Projects |
190,555,538.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
436,864,105.21 |
| R&D expenses |
-- |
| Goodwill |
135,775,039.32 |
| Long-Term Deferred and Prepaid Expenses |
368,483,951.34 |
| Deferred Income Tax Assets |
70,416,484.12 |
| Other Non-Current Assets |
886,898,615.00 |
| Sub-Total of Non-Current Assets |
5,068,226,354.20 |
| Total Assets |
10,471,265,089.14 |
| Short-Term Loans |
1,697,789,400.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
163,759,699.61 |
| Accounts Payable |
366,862,066.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
78,870,412.09 |
| Taxes Payable |
63,563,957.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,347,692.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,199,442.48 |
| Other Current Liabilities |
711,994.31 |
| Sub-Total of Current Liabilities |
2,404,333,583.50 |
| Long-term Loans |
-- |
| Bonds Payable |
1,460,213,355.54 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,706,450.23 |
| Deferred Income Tax Liabilities |
83,073,818.51 |
| Other Non-Current Liabilities |
550,549,333.98 |
| Sub-Total of Non-Current Liabilities |
2,247,441,230.41 |
| Total Liabilities |
4,651,774,813.91 |
| Paid-In Capital(Or Share Stock) |
883,263,595.00 |
| Capital Surplus |
2,174,910,503.97 |
| Surplus Reserve |
352,128,747.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,046,319,672.77 |
| Minority Stockholder's Interest |
217,295,234.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,602,195,040.28 |
| Owner's Equity（Stockholder's Equity） |
5,819,490,275.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,471,265,089.14 |
